https://lmct.research.vub.be/

Projects

Projects per year 2014 2016 2017 2018 2024

• 9 Active
• 20 Finished

Projects per year

Search results

• Active

  IOFACC9B: IOF Accelerator:Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

  Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K. & Goyvaerts, C.

  1/10/22 → 31/03/24

  Project: Applied

• IOFPOC55: PoC project ROTEA-DC Implementing the RoteaTM technology in dendritic cell manufacturing

  Breckpot, K.

  15/07/22 → 14/07/23

  Project: Applied

• BRGRD44: Joint R&D 2020: "IMPACT: Invigorating precision Medicine by Predictive imaging of sdAb-based anti-Cancer Theranostics"

  Keyaerts, M., Krasniqi, A., Breckpot, K. & Goyvaerts, C.

  1/07/20 → 30/06/23

  Project: Applied

• IOF3013: GEAR: Brussels Liver Research to Valorisation Alliance (B-Liver): Valorisation of VUB’s liver cell biology and toxicology expertise via a consortium focused on liver therapeutics, patient and consumer safety.

  Vanhaecke, T., van Grunsven, L., De Kock, J., Vinken, M. & Reynaert, H.

  1/01/20 → 31/12/24

  Project: Applied

• IOF3009: GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

  Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K. & Goyvaerts, C.

  1/01/20 → 31/12/24

  Project: Applied

• FWOTBM3: A randomized phase II clinical trial in NSCLC combining SBRT and I.V. anti-PD-1 with or without I.T. anti-CTLA-4/anti-PD-L1 plus CD1c+ myDC

  Neyns, B.

  1/10/19 → 30/09/23

  Project: Applied

• SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

  Vanderkerken, K., Thielemans, K., Vanderkerken, K. & Breckpot, K.

  1/11/17 → 31/10/24

  Project: Fundamental

• EU497: European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

  Thielemans, K. & Breckpot, K.

  European Commission

  1/01/16 → 30/06/23

  Project: Fundamental

• OZR2835: Onderzoeksgroep Alliantie VUB - UGent - Research Consortium on particle based immunotherapy

  Breckpot, K. & De Smedt, S.

  10/07/15 → 10/07/24

  Project: Policy Based

• Finished

  FWOSB81: Eccentric: Enhancing the function of Cancer Countering Effector cells using Nanobodies Targeting Regulatory Immune Checkpoints

  Breckpot, K., Devoogdt, N., Keyaerts, M. & Awad, R. M.

  1/11/19 → 31/10/21

  Project: Fundamental

• FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.

  Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.

  1/11/19 → 31/10/21

  Project: Fundamental

• FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.

  Breckpot, K., De Beck, L. & Maes, K.

  1/10/18 → 30/09/22

  Project: Fundamental

• IWTOO24: Baekeland mandate: preclinical development of an mRNA cancer vaccine for intravenous administration

  Thielemans, K. & Bevers, S.

  1/02/18 → 31/01/22

  Project: Applied

• OZR3204: Polyvac: development of an optimized polytope vaccine (OZR backup mandate)

  Thielemans, K.

  1/01/18 → 31/12/18

  Project: Applied

• IWTOO25: Baekeland mandate: In situ mRNA vaccination: bringing the fight to the tumor

  Breckpot, K., Thielemans, K. & Locy, H.

  1/01/18 → 30/11/22

  Project: Applied

• FWOKN302: Target and explore the ‘X factor’ of the lung tumor microenvironment.

  Goyvaerts, C., Breckpot, K. & Thielemans, K.

  1/01/18 → 31/12/18

  Project: Fundamental

• FWOSBO21: SBO: MATATUM : Validation and druggability development of macrophage-specific targets in the tumor microenvironment

  Van Ginderachter, J., Breckpot, K., Lahoutte, T., Devoogdt, N. & Raes, G.

  1/01/18 → 31/12/21

  Project: Applied

• AIIFUND14: Development of navel anti-checkpoint strategies based on nanobodies.

  Breckpot, K., Devoogdt, N. & Keyaerts, M.

  15/05/17 → 14/05/21

  Project: Fundamental

• EU529: Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection (HIVACAR)

  Thielemans, K. & Breckpot, K.

  European Commission

  1/01/17 → 30/06/22

  Project: Fundamental

• ANI184: Nanobody-targeted radionuclide therapy and immune therapy: a perfect match in the area of combination therapy.

  Breckpot, K. & Keyaerts, M.

  1/01/17 → 31/12/21

  Project: Fundamental

• ANI160: Beurs Emmanuel Van der Schueren: The Trojan Horse: an old strategy coming of age to explore and defeat tumors from within

  Breckpot, K. & Goyvaerts, C.

  1/10/16 → 30/09/19

  Project: Fundamental

• ANI173: Nanobody-mediated imaging and blocking of the inhibitory receptor LAG3.

  Breckpot, K. & Lecocq, Q.

  1/10/16 → 30/09/17

  Project: Fundamental

• OZR3008: Prijs Kankeronderzoek 2016 - Startersbeurs tbv S. Melhaoui

  De Keersmaecker, B.

  10/08/16 → 10/08/20

  Project: Policy Based

• OZR3007: Prijs Kankeronderzoek 2016 - Startersbeurs tbv Y. De Vlaeminck

  Breckpot, K.

  10/08/16 → 10/08/20

  Project: Policy Based

• OZR3022: Bilaterale samenwerking ikv gemeenschappelijk doctoraatsproject: Bench Fee voor Joint PhD VUB-UGent, Schreuer Max

  Neyns, B.

  18/05/16 → 30/09/19

  Project: Fundamental

• FWOAL809: Rationally designed therapeutic vaccine against HIV-1 based on a novel formulation of nanoparticle-protected mRNA

  Aerts, J.

  1/01/16 → 31/12/18

  Project: Fundamental

• ANI146: Targeting Tumor-Associated Macrophages using lentiviral vectors and nanobodies.

  Breckpot, K. & De Vlaeminck, Y.

  1/10/15 → 30/09/16

  Project: Fundamental

• ANI144: NICHE: Nanobody-mediated Immune CHEckpoint imaging and inhibition

  Breckpot, K., Thielemans, K. & Devoogdt, N.

  1/10/15 → 30/09/21

  Project: Fundamental

• IWTTBM12: Dendritic cell-based immunotherapy in combination with lenalidomide maintenance after autologous stem cell transplantation in multilple myeloma patients with low disease burden.

  Schots, H.

  1/09/14 → 31/08/18

  Project: Fundamental